Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR.21 and SATURN trials

Por Osarogiagbon, Raymond U., Cappuzzo, Federico, Ciuleanu, Tudor, Leon, Larry, Klughammer, Barbara
Publicado no Transl Lung Cancer Res (2015)

Impact of dose calculation models on radiotherapy outcomes and quality adjusted life years for lung...

Por Chaikh, Abdulhamid, Docquière, Nicolas, Bondiau, Pierre-Yves, Balosso, Jacques
Publicado no Transl Lung Cancer Res (2016)

The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention

Por Domagala-Kulawik, Joanna
Publicado no Transl Lung Cancer Res (2015)

Differential microRNA expression profiles between young and old lung adenocarcinoma patients

Por Giordano, Mirella, Boldrini, Laura, Servadio, Adele, Niccoli, Cristina, Melfi, Franca, Lucchi, Marco, Mussi, Alfredo, Fontanini, Gabriella
Publicado no Am J Transl Res (2018)

The relationship between BIM deletion polymorphism and clinical significance of epidermal growth factor receptor-mutated non-small cell lung cancer patients with epidermal growth factor receptor...

Por Zou, Qian, Zhan, Ping, Lv, Tangfeng, Song, Yong
Publicado no Transl Lung Cancer Res (2015)

Future perspectives in cancer immunotherapy

Por Tsiatas, Marinos, Mountzios, Giannis, Curigliano, Giuseppe
Publicado no Ann Transl Med (2016)

Can we omit radiotherapy in case of brain metastases for patients with mutant EGFR lung adenocarcinoma?

Por Van Houtte, Paul Jules, Devriendt, Daniel
Publicado no Transl Lung Cancer Res (2017)

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Por Kim, Hyojin, Chung, Jin-Haeng
Publicado no Transl Lung Cancer Res (2015)

MicroRNA-214 inhibits the proliferation and invasion of lung carcinoma cells by targeting JAK1

Por Chen, Xiaofeng, Du, Jiangyuan, Jiang, Rui, Li, Ling
Publicado no Am J Transl Res (2018)

MET exon 14 deletion (METex14): finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of “40 years of wilderness” and into a clear...

Por Reungwetwattana, Thanyanan, Ou, Sai-Hong Ignatius
Publicado no Transl Lung Cancer Res (2015)

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

Por Mendez, Pedro, Ramirez, Jose Luis
Publicado no Transl Lung Cancer Res (2013)

Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index

Por Chaikh, Abdulhamid, Balosso, Jacques
Publicado no Transl Lung Cancer Res (2016)

Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016

Por Seabloom, Donna E, Galbraith, Art R, Haynes, Anna M, Fujita, Alisha S, Antonides, Jenny D, Wuertz, Beverly R, Steele, Vernon E, Ondrey, Frank G, Wattenberg, Lee W
Publicado no Am J Transl Res (2018)

Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma

Por Miao, Yingying, Zhang, Jianya, Zou, Jiawei, Zhu, Qingqing, Lv, Tangfeng, Song, Yong
Publicado no Transl Lung Cancer Res (2017)

Prognostic significance of aromatase and estrogen receptor beta expression in EGFR wild-type lung adenocarcinoma

Por Tanaka, Kazumi, Shimizu, Kimihiro, Kakegawa, Seiichi, Ohtaki, Yoichi, Nagashima, Toshiteru, Kaira, Kyoichi, Horiguchi, Jun, Oyama, Tetsunari, Takeyoshi, Izumi
Publicado no Am J Transl Res (2016)

Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature

Por Kim, Chul, Rajan, Arun, DeBrito, Pedro A., Giaccone, Giuseppe
Publicado no Transl Lung Cancer Res (2016)

Integrative physicians and an herbal cancer “cure”

Por Ben-Arye, Eran, Rosenberg, Shoshana Keren, Samuels, Noah
Publicado no Transl Lung Cancer Res (2016)

The emerging role of immunotherapy in colorectal cancer

Por Lynch, David, Murphy, Adrian
Publicado no Ann Transl Med (2016)

Adaptive resistance to targeted therapies in cancer

Por Rosell, Rafael, Karachaliou, Niki, Morales-Espinosa, Daniela, Costa, Carlota, Molina, Miguel Angel, Sansano, Irene, Gasco, Amaya, Viteri, Santiago, Massuti, Bartomeu, Wei, Jia, González Cao, María, Martínez Bueno, Alejandro
Publicado no Transl Lung Cancer Res (2013)

P16. Is type of EGFR mutation predictive for incidence and survival in lung adenocarcinoma patients with brain metastases?

Por Stanic, Karmen, Hitij, Nina Turnsek
Publicado no Transl Lung Cancer Res (2014)